Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BRM.DE Stock Summary
Top 10 Correlated ETFs
BRM.DE
In the News
BRM.DE Financial details
Company Rating
Strong Buy
Market Cap
101.43B
Income
8.03B
Revenue
45.01B
Book val./share
-
Cash/share
-
Dividend
1.14
Dividend %
2.42%
Employees
34.3K
Optionable
No
Shortable
Yes
Earnings
26 Oct 2023
P/E
13.57
Forward P/E
6.98
PEG
100.76
P/S
2.39
P/B
3.38
P/C
-
P/FCF
10.06
Quick Ratio
1.18
Current Ratio
1.39
Debt / Equity
1.41
LT Debt / Equity
1.29
-
-
EPS (TTM)
3.01
EPS next Y
7.18
EPS next Q
-
EPS this Y
-
EPS next Y
138.57%
EPS next 5Y
127.02%
EPS last 5Y
-
Revenue last 5Y
11.47%
Revenue Q/Q
4.66%
EPS Q/Q
-
-
-
-
-
SMA20
2.86%
SMA50
4.75%
SMA100
-1.21%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
25%
ROC
0.14%
Gross Margin
77%
Oper. Margin
23%
Profit Margin
18%
Payout
59%
Shs Outstand
2.09B
Shs Float
2.09B
-
-
-
-
Target Price
-
52W Range
44.2-64.9
52W High
-21.72%
52W Low
+13.86%
RSI
67.52
Rel Volume
0.75
Avg Volume
2.36K
Volume
1.77K
Perf Week
4.59%
Perf Month
9.15%
Perf Quarter
-6.36%
Perf Half Y
-9.73%
-
-
-
-
Beta
0.408367
-
-
Volatility
0.9%, 1.09%
Prev Close
1.73%
Price
50.1
Change
1.83%
BRM.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.27 | 18.83 | 20.66 | 21.51 | 0 | |
Net income per share | 2.01 | -3.98 | 3.12 | 2.95 | 0 | |
Operating cash flow per share | 4.71 | 6.22 | 7.22 | 6.09 | 0 | |
Free cash flow per share | 4.22 | 5.89 | 6.79 | 5.57 | 0 | |
Cash per share | 8.99 | 7.01 | 7.67 | 4.31 | 0 | |
Book value per share | 30.14 | 16.75 | 16.01 | 14.47 | 0 | |
Tangible book value per share | -20.3 | -15.9 | -12.15 | -12.3 | 0 | |
Share holders equity per share | 30.14 | 16.75 | 16.01 | 14.47 | 0 | |
Interest debt per share | 28.15 | 23.51 | 20.9 | 19.55 | 0 | |
Market cap | 110.29B | 140.09B | 140.22B | 153.68B | 0 | |
Enterprise value | 145.49B | 177.21B | 171.83B | 185.28B | 30B | |
P/E ratio | 32.07 | -15.57 | 20.05 | 24.29 | 0 | |
Price to sales ratio | 4.22 | 3.29 | 3.02 | 3.33 | 0 | |
POCF ratio | 13.67 | 9.97 | 8.65 | 11.76 | 0 | |
PFCF ratio | 15.25 | 10.53 | 9.2 | 12.86 | 0 | |
P/B Ratio | 2.14 | 3.7 | 3.9 | 4.95 | 0 | |
PTB ratio | 2.14 | 3.7 | 3.9 | 4.95 | 0 | |
EV to sales | 5.56 | 4.17 | 3.7 | 4.01 | 0.67 | |
Enterprise value over EBITDA | 22.05 | 11.96 | 8.51 | 9.3 | 1.56 | |
EV to operating cash flow | 18.03 | 12.61 | 10.6 | 14.18 | 2.16 | |
EV to free cash flow | 20.12 | 13.33 | 11.28 | 15.51 | 2.37 | |
Earnings yield | 0.03 | -0.06 | 0.05 | 0.04 | 0 | |
Free cash flow yield | 0.07 | 0.09 | 0.11 | 0.08 | 0 | |
Debt to equity | 0.92 | 1.37 | 1.27 | 1.31 | 1.41 | |
Debt to assets | 0.37 | 0.44 | 0.42 | 0.42 | 0.44 | |
Net debt to EBITDA | 5.33 | 2.51 | 1.57 | 1.59 | 1.56 | |
Current ratio | 1.6 | 1.58 | 1.52 | 1.25 | 1.43 | |
Interest coverage | 8.33 | 3.61 | 7.62 | 8.38 | 8.08 | |
Income quality | 2.33 | -1.56 | 2.31 | 2.06 | 1.72 | |
Dividend Yield | 0.02 | 0.03 | 0.03 | 0.03 | 0 | |
Payout ratio | 0.78 | -0.45 | 0.63 | 0.73 | 0.59 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.24 | 0.26 | 0.22 | 0.21 | 0.21 | |
Intangibles to total assets | 0.67 | 0.62 | 0.58 | 0.59 | 0.51 | |
Capex to operating cash flow | -0.1 | -0.05 | -0.06 | -0.09 | -0.09 | |
Capex to revenue | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 | |
Capex to depreciation | -0.48 | -0.07 | -0.09 | -0.11 | -0.12 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham number | 36.91 | 38.75 | 33.5 | 30.99 | 0 | |
ROIC | 0.04 | 0.07 | 0.11 | 0.12 | 0.12 | |
Return on tangible assets | 0.08 | -0.2 | 0.15 | 0.16 | 0.17 | |
Graham Net | -32.09 | -25.4 | -20.34 | -20.89 | 0 | |
Working capital | 11.05B | 11.11B | 11.39B | 5.38B | 9.51B | |
Tangible asset value | -34.76B | -35.91B | -27.27B | -26.39B | -19.17B | |
Net current asset value | -48.89B | -50.41B | -40.05B | -38.43B | -33.9B | |
Invested capital | 0.92 | 1.37 | 1.27 | 1.31 | 1.41 | |
Average receivables | 6.83B | 8.09B | 10.51B | 13.23B | 14.6B | |
Average payables | 2.17B | 2.58B | 2.83B | 2.99B | 3.15B | |
Average inventory | 2.74B | 3.18B | 2.08B | 2.22B | 2.5B | |
Days sales outstanding | 107.29 | 72.98 | 98.49 | 110.21 | 123.79 | |
Days payables outstanding | 110.48 | 84.11 | 108.29 | 109.46 | 111.24 | |
Days of inventory on hand | 193.98 | 64.3 | 76.93 | 84.22 | 90.87 | |
Receivables turnover | 3.4 | 5 | 3.71 | 3.31 | 2.95 | |
Payables turnover | 3.3 | 4.34 | 3.37 | 3.33 | 3.28 | |
Inventory turnover | 1.88 | 5.68 | 4.74 | 4.33 | 4.02 | |
ROE | 0.07 | -0.24 | 0.19 | 0.2 | 0.27 | |
Capex per share | -0.49 | -0.33 | -0.43 | -0.52 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.37 | 5.37 | 5.34 | 5.31 | 0 | |
Net income per share | 0.95 | 1.07 | 0.99 | 0.93 | 0 | |
Operating cash flow per share | 1.56 | 1.41 | 0.9 | 2.3 | 0 | |
Free cash flow per share | 1.39 | 1.27 | 0.77 | 2.14 | 0 | |
Cash per share | 4.36 | 4.39 | 4.15 | 3.72 | 0 | |
Book value per share | 14.62 | 15.06 | 15.21 | 14.05 | 0 | |
Tangible book value per share | -12.42 | -11.04 | -9.95 | -10.4 | 0 | |
Share holders equity per share | 14.62 | 15.06 | 15.21 | 14.05 | 0 | |
Interest debt per share | 19.31 | 18.77 | 18.78 | 19.16 | 0 | |
Market cap | 152.11B | 146.66B | 134.26B | 120.11B | 0 | |
Enterprise value | 183.7B | 177.04B | 165.08B | 151.87B | 30B | |
P/E ratio | 18.81 | 16.21 | 16.19 | 15.57 | 0 | |
Price to sales ratio | 13.34 | 12.94 | 11.96 | 10.95 | 0 | |
POCF ratio | 46.01 | 49.38 | 71.15 | 25.28 | 0 | |
PFCF ratio | 51.39 | 54.48 | 82.47 | 27.24 | 0 | |
P/B Ratio | 4.9 | 4.61 | 4.2 | 4.14 | 0 | |
PTB ratio | 4.9 | 4.61 | 4.2 | 4.14 | 0 | |
EV to sales | 16.11 | 15.62 | 14.7 | 13.85 | 2.61 | |
Enterprise value over EBITDA | 38.97 | 34.74 | 35.68 | 30.62 | 7.23 | |
EV to operating cash flow | 55.57 | 59.61 | 87.48 | 31.96 | 7.06 | |
EV to free cash flow | 62.06 | 65.76 | 101.4 | 34.44 | 7.65 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.02 | 0 | |
Free cash flow yield | 0.02 | 0.02 | 0.01 | 0.04 | 0 | |
Debt to equity | 1.31 | 1.24 | 1.23 | 1.35 | 1.41 | |
Debt to assets | 0.42 | 0.42 | 0.42 | 0.43 | 0.44 | |
Net debt to EBITDA | 6.7 | 5.96 | 6.66 | 6.4 | 7.23 | |
Current ratio | 1.25 | 1.42 | 1.39 | 1.18 | 1.43 | |
Interest coverage | 8.06 | 9.86 | 8.4 | 9.01 | 5.33 | |
Income quality | 1.63 | 1.31 | 0.91 | 2.46 | 2.41 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Payout ratio | 0.57 | 0.53 | 0.58 | 0.62 | 0.66 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.22 | 0.2 | 0.2 | 0.2 | 0.22 | |
Intangibles to total assets | 0.59 | 0.59 | 0.57 | 0.55 | 0.51 | |
Capex to operating cash flow | -0.1 | -0.09 | -0.14 | -0.07 | -0.08 | |
Capex to revenue | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 | |
Capex to depreciation | -0.14 | -0.11 | -0.11 | -0.14 | -0.13 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 17.7 | 19.05 | 18.37 | 17.18 | 0 | |
ROIC | 0.04 | 0.03 | 0.04 | 0.03 | 0.02 | |
Return on tangible assets | 0.05 | 0.06 | 0.05 | 0.05 | 0.04 | |
Graham Net | -21.1 | -19.77 | -19.15 | -20.14 | 0 | |
Working capital | 5.38B | 8B | 7.92B | 4.17B | 9.51B | |
Tangible asset value | -26.39B | -23.33B | -20.91B | -21.46B | -19.17B | |
Net current asset value | -38.43B | -35.31B | -33.39B | -34.57B | -33.9B | |
Invested capital | 1.31 | 1.24 | 1.23 | 1.35 | 1.41 | |
Average receivables | 13.59B | 13.67B | 14.23B | 15.35B | 15.46B | |
Average payables | 2.82B | 3.12B | 3.13B | 2.94B | 3.04B | |
Average inventory | 2.21B | 2.47B | 2.48B | 2.4B | 2.55B | |
Days sales outstanding | 109.97 | 106.42 | 120.73 | 128.42 | 119.7 | |
Days payables outstanding | 105.51 | 112.03 | 96.04 | 101.03 | 106.85 | |
Days of inventory on hand | 81.18 | 91.37 | 73.98 | 87.49 | 87.28 | |
Receivables turnover | 0.82 | 0.85 | 0.75 | 0.7 | 0.75 | |
Payables turnover | 0.85 | 0.8 | 0.94 | 0.89 | 0.84 | |
Inventory turnover | 1.11 | 0.99 | 1.22 | 1.03 | 1.03 | |
ROE | 0.07 | 0.07 | 0.06 | 0.07 | 0.06 | |
Capex per share | -0.16 | -0.13 | -0.12 | -0.17 | 0 |
BRM.DE Frequently Asked Questions
What is Bristol-Myers Squibb Company stock symbol ?
Bristol-Myers Squibb Company is a US stock , located in New york of Ny and trading under the symbol BRM.DE
What is Bristol-Myers Squibb Company stock quote today ?
Bristol-Myers Squibb Company stock price is $50.1 today.
Is Bristol-Myers Squibb Company stock public?
Yes, Bristol-Myers Squibb Company is a publicly traded company.